AZN vs JNJ
AstraZeneca PLC · Johnson & Johnson
Relative return (rebased to 100)
Key stats
| Metric | AZN | JNJ |
|---|---|---|
| Price | $155.62 | $254.93 |
| Market Cap | $241.21B | $613.67B |
| P/E | 23.59 | 22.89 |
| P/B | 4.96 | 7.56 |
| P/S | 4.11 | 6.52 |
| ROE | 21.0% | 33.0% |
| Net Margin | 17.4% | 28.5% |
| Gross Margin | 81.9% | 67.9% |
| Revenue Growth | 8.6% | 6.0% |
| Dividend Yield | 2.01% | 2.02% |
| EPS | $6.60 | $11.13 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.